Combinate BioWorks
QMSR for combination products.
Assess how QMSR applies through 21 CFR Part 4, clarify the drug-device quality-system interfaces, and give process owners a practical implementation plan.
Apply QMSR within the 21 CFR Part 4 combination-product framework.
21 CFR Part 4 continues to define how drug and device CGMP requirements apply to combination products. QMSR changes the device-quality framework within that operating system. The practical challenge is determining what that means for procedures, responsibilities, records, and cross-functional evidence.
- You need to assess the current Part 4 operating approach against the revised QMSR framework.
- A pharmaceutical quality system must incorporate applicable device-quality requirements without creating a disconnected second system.
- Process owners need clarity across design and development, risk, supplier controls, change, CAPA, and management responsibility.
- Teams need role-specific training tied to the procedures and evidence they actually own.
The work can be structured as a QMSR–Part 4 assessment, process-owner workshop, targeted training program, or combined engagement.